Icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis

Journal of Biomaterials Applications

Volumn 30, Issue 3, 2015, Pages 290-299

  Xie, Xiaowei ^a   Pei, Fuxing ^a   Wang, Haoyang ^a   Tan, Zhen ^a   Yang, Zhouyuan ^a   Kang, Pengde ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

angiogenesis; bone defect; Bone tissue engineering; icariin; osteogenesis; osteonecrosis of the femoral head

Indexed keywords

BONE; DEFECTS; FLAVONOIDS; POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TRANSMISSION CONTROL PROTOCOL;

ANGIOGENESIS; BONE DEFECT; BONE TISSUE ENGINEERING; FEMORAL HEADS; ICARIIN; OSTEOGENESIS;

REPAIR;

CALCIUM PHOSPHATE; ICARIIN; MESSENGER RNA; VASCULOTROPIN; FLAVONOID; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE DISEASE; BONE GRAFT; BONE NECROSIS; CONTROLLED STUDY; FEMORAL HEAD COLLAPSE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BONE; CONGENITAL MALFORMATION; GENETICS; METABOLISM; OSTEONECROSIS;

ANIMALS; BONE AND BONES; FLAVONOIDS; MALE; OSTEONECROSIS; RABBITS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942122308     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328215581551     Document Type: Article

References (48)

1. Mont MA, Zywiel MG, Marker DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am 2010; 92: 2165-2170.
2. Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res 2010; 468: 2715-2724.
3. OIssa K, Pivec R, Kapadia BH, et al. Osteonecrosis of the femoral head: the total hip replacement solution. Bone Joint J 2013; 95: 46-50.
4. Marker DR, Seyler TM, McGrath MS, et al. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 2008; 90: 175-187.
5. McGrory BJ, York Sally C, Iorio R, et al. Current practices of AAHKS members in the treatment of adult osteonecrosis of the femoral head. J Bone Joint Surg Am 2007; 89: 1194-1204.
6. Cui Q, Botchwey EA,. Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors. Clin Orthop Relat Res 2011; 469: 2665-2669.
7. Kang P, Shen B, Yang J, et al. Repairing defect and preventing collapse of canine femoral head using titanium implant enhanced by autogenous bone graft and rhBMP-2. Connect Tissue Res 2007; 48: 171-179.
8. Dorozhkin SV,. Calcium orthophosphate-based bioceramics. Materials 2013; 6: 3840-3942.
9. Dorozhkin SV,. Biphasic, triphasic and multiphasic calcium orthophosphates. Acta Biomater 2012; 8: 963-977.
10. Miramond T, Corre P, Borget P, et al. Osteoinduction of biphasic calcium phosphate scaffolds in a nude mouse model. J Biomater Appl 2014; 29: 595-604.
11. Kroese-Deutman HC, Ruhe PQ, Spauwen PHM, et al. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 2005; 26: 1131-1138.
12. Nath SD, Linh NT, Sadiasa A, et al. Encapsulation of simvastatin in PLGA microspheres loaded into hydrogel loaded BCP porous spongy scaffold as a controlled drug delivery system for bone tissue regeneration. J Biomater Appl 2014; 28: 1151-1163.
13. Seeherman HJ, Azari K, Bidic S, et al. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 2006; 88: 1553-1565.
14. Hoshino M, Egi T, Terai H, et al. Repair of long intercalated rib defects using porous beta-tricalcium phosphate cylinders containing recombinant human bone morphogenetic protein-2 in dogs. Biomaterials 2006; 27: 4934-4940.
15. Garrison KR, Shemilt I, Donell S, et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev 2010; 6: CD006950-CD006950.
16. Simmonds MC, Brown JV, Heirs MK, et al. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med 2013; 158: 877-889.
17. Zhao B, Katagiri T, Toyoda H, et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 2006; 281: 23246-23253.
18. Singh K, Ahmadinia K, Park DK, et al. Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature. Spine 2014; 39: 91-101.
19. Zhang G, Qin L, Shi Y,. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res 2007; 22: 1072-1079.
20. Zhu HM, Qin L, Garnero P, et al. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis. Osteoporos Int 2012; 23: 1317-1327.
21. Zheng D, Peng S, Yang SH, et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. Bone 2012; 51: 85-92.
22. Ma HP, Ming LG, Ge BF, et al. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem 2011; 112: 916-923.
23. Zhao J, Ohba S, Shinkai M, et al. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Biochem Biophys Res Commun 2008; 369: 444-448.
24. Mok SK, Chen WF, Lai WP, et al. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 2010; 159: 939-949.
25. Fan J, Bi L, Wu T, et al. A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin. J Mater Sci Mater Med 2012; 23: 399-407.
26. Zhao J, Ohba S, Komiyama Y, et al. Icariin: a potential osteoinductive compound for bone tissue engineering. Tissue Eng Part A 2010; 16: 233-243.
27. Chung BH, Kim JD, Kim CK, et al. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun 2008; 376: 404-408.
28. Zhang X, Guo Y, Li DX, et al. The effect of loading icariin on biocompatibility and bioactivity of porous β-TCP ceramic. J Mater Sci Mater Med 2011; 22: 371-379.
29. Wang XL, Xie XH, Zhang G, et al. Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair. J Orthop Res 2013; 31: 164-172.
30. Miyanishi K, Yamamoto T, Irisa T, et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 2002; 30: 185-190.
31. Kang PD, Pei FX, Shen B, et al. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 2008; 75: 696-701.
32. Kang P, Xie X, Tan Z, et al. Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs. J Mater Sci Mater Med 2015; 26: 5402-5410.
33. Mont MA, Jones LC, Elias JJ, et al. Strut-autografting with and without osteogentic protein-1: a preliminary study of a canine femoral head defect model. J Bone Join Surg Am 2001; 83: 1013-1022.
34. Peled E, Davis M, Axelman E, et al. Heparanase role in the treatment of avascular necrosis of femur head. Thromb Res 2013; 131: 94-98.
35. Li W, Sakai T, Nishii T, et al. Distribution of TRAP-positive cells and expression of HIF-1alpha, VEGF, and FGF-2 in the reparative reaction in patients with osteonecrosis of the femoral head. J Orthop Res 2009; 27: 694-700.
36. Ko JY, Wang FS, Wang CJ, et al. Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis. Bone 2010; 46: 584-591.
37. Zalavras CG, Lieberman JR,. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg 2014; 22: 455-464.
38. Stegen S, van Gastel N, Carmeliet G,. Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone 2015; 70: 19-27.
39. Hsieh TP, Sheu SY, Sun JS, et al. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine 2010; 17: 414-423.
40. Hsieh TP, Sheu SY, Sun JS, et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-B regulated HIF-1α and PGE(2) synthesis. Phytomedicine 2011; 18: 176-185.
41. Zhang L, Zhang X, Li KF, et al. Icariin promotes extracellular matrix synthesis and gene expression of chondrocytes in vitro. Phytother Res 2012; 26: 1385-1392.
42. Zhang X, Xu M, Song L, et al. Effects of compatibility of deproteinized antler cancellous bone with various bioactive factors on their osteogenic potential. Biomaterials 2013; 34: 9103-9114.
43. Wernike E, Montjovent MO, Liu Y, et al. VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. Eur Cell Mater 2010; 19: 30-40.
44. Koizumi H, Yu J, Hashimoto R, et al. Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells. FEBS Lett 2010; 584: 2440-2444.
45. Xu HB, Huang ZQ,. Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro. Vascul Pharmacol 2007; 47: 18-24.
46. Zhang X, Liu T, Huang Y, et al. Icariin: does it have an osteoinductive potential for bone tissue engineering? Phytother Res 2014; 28: 498-509.
47. Sun ZB, Wang JW, Xiao H, et al. Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study. Osteoporos Int 2015; 26: 187-197.
48. Li D, Yuan T, Zhang X, et al. Icariin: a potential promoting compound for cartilage tissue engineering. Osteoarthr Cartil 2012; 20: 1647-1656.